Lung nodule study using blood and tissue metabolism
Part of Cancer, Lungs & breathing clinical trials.
This trial follows people with lung nodules over time, using blood and tissue samples to look for metabolic changes that may help understand lung cancer better. If you have a lung nodule found on a CT scan and can safely do lung function tests, this study may be a fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have a lung nodule seen on a CT scan
- You are willing and able to have lung function tests and CT scans before surgery
- Your CT scans and lung function tests must be done within one month of each other
- You cannot have severe breathing problems or blockages in your airways or esophagus
- You must not be on certain medications that would interfere with lung function testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
This study collects blood, tissue, and other samples from people with lung nodules, suspected lung cancer, or confirmed lung cancer to find better ways to diagnose and treat the disease. By joining, you help researchers discover new biomarkers that could improve care for future patients.
This study looks at whether MRI scans and blood-related biomarkers can help better understand lung nodules found during routine lung cancer screening. It may help doctors decide which nodules need closer follow-up versus less intensive monitoring.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.